A prior phase II trial had shown that BCG revaccination in teens led to 45.4% efficacy in reversion from positive to negative ...

Kennedy Jr pledged last week that his department will now require all new vaccines to be tested in placebo-controlled trials ...

With its twice-yearly dosing, the siRNA-based drug might lead to better compliance with treatment. Still, cost is an issue.

A new case report published in Clinical Neurophysiology describes the first known administration of psilocybin—a psychedelic ...